<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02570503</url>
  </required_header>
  <id_info>
    <org_study_id>HM20004125</org_study_id>
    <nct_id>NCT02570503</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty</brief_title>
  <official_title>Do Intraoperative Periarticular Injections Improve Postoperative Pain Control in Patients Receiving Duramorph (Preservative Free) During Total Knee Arthroplasty? A Prospective, Double-Blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the use of a local injection around the knee (periarticular) during&#xD;
      total knee replacement (TKR) surgery to see if it reduces postoperative pain levels. The&#xD;
      injection is a combination of various medications which are thought to reduce pain levels.&#xD;
&#xD;
      Approximately 128 patients will participate in this study, half of the patients will receive&#xD;
      this injection during surgery and the other half will receive a saline (salt water)&#xD;
      injection. Pain scores after the surgery will be compared between the two groups.&#xD;
&#xD;
      All patients will also receive a long-acting (24 hours) morphine injection during surgery.&#xD;
&#xD;
      The hypothesis is that those participants receiving intrathecal Duramorph and local&#xD;
      periarticular injections will have improved pain scores and reduced narcotic use when&#xD;
      compared with intrathecal Duramorph alone at 48 hours postoperatively.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data Collection:&#xD;
&#xD;
      Data will be collected from the patient's medical record after discharge&#xD;
&#xD;
      Variables include:&#xD;
&#xD;
        -  Age&#xD;
&#xD;
        -  Sex&#xD;
&#xD;
        -  BMI&#xD;
&#xD;
        -  UPAT score (Universal Pain Assessment Tool)- this is assessed hourly postoperatively by&#xD;
           nursing staff on Orthopedics Unit&#xD;
&#xD;
        -  Patient's assessment of acceptability of pain&#xD;
&#xD;
        -  UPAT score as assessed by physical therapy pre and post therapy sessions&#xD;
&#xD;
        -  Duramorph dose&#xD;
&#xD;
        -  Time patient arrived on the Orthopedic Unit&#xD;
&#xD;
        -  Length of ambulation during physical therapy sessions&#xD;
&#xD;
        -  Amount of supplementary opioids (measured in morphine equivalents)&#xD;
&#xD;
        -  Use of anti-emetics&#xD;
&#xD;
        -  Any complications of surgery including venous thromboembolic event, cardiac event,&#xD;
           bleeding event&#xD;
&#xD;
        -  Length of hospital stay&#xD;
&#xD;
      The pharmacist will randomize patients to either study arm, prepare the injection and&#xD;
      maintain dispensing records.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study's primary aims are no longer clinically impactful, as intrathecal morphine has fallen out&#xD;
    of favor and replaced with different agents so that outpatient/23 hr surgery is more&#xD;
    predictably achievable.&#xD;
  </why_stopped>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">February 11, 2021</completion_date>
  <primary_completion_date type="Actual">February 11, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Universal Pain Assessment Tool (UPAT)</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Patient's pain scores will be measured with the UPAT scale which ranges from 0 (no pain) to 10 (severe pain) This is measured hourly while the patient is awake after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's subjective rating of pain</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Patients are asked if their pain is acceptable (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic Use During Hospitalization</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>The amount of narcotic pain medication needed for patient to be comfortable. This is measured in morphine equivalents since there are many pain medications other than morphine.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UPAT Score Before and After Physical Therapy</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Pain in score change after physical therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ambulation During Physical Therapy</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>The length (in feet) patient is able to ambulate during physical therapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine (ROP) (5mg/ml)- 50ml Ketorolac (KET) (30mg/ml)- 1ml Clonidine (CLON) (0.1mg/ml)- 0.8ml Epinephrine (EPI) (1mg/ml)- 0.5ml 0.9% sodium chloride SAL)--47.7 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% Sodium Chloride- 100ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Ropivacaine (5mg/ml)-50ml</description>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <other_name>periarticular injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>ketorolac (30mg/ml)- 1 ml</description>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <other_name>periarticular injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clonidine</intervention_name>
    <description>clonidine (0.1mg/ml)- 0.8ml</description>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <other_name>periarticular injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>epinephrine (1mg/ml)-1ml</description>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <other_name>periarticular injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% sodium chloride</intervention_name>
    <description>Sodium chloride 0.9%- 47.7 ml</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>ROP/KET/CLON/EPI/SAL</arm_group_label>
    <other_name>periarticular injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 or older&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Creatinine clearance less than 60 ml/min&#xD;
&#xD;
          -  BMI greater than 40&#xD;
&#xD;
          -  Currently use greater than 80mg morphine-equivalents daily (pre-operatively)&#xD;
&#xD;
          -  Receive a unicondylar knee replacement&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory Golladay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 5, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

